Both endothelium-dependent and endothelium-independent function is impaired in patients with angina pectoris and normal coronary angiograms.

PubWeight™: 1.69‹?› | Rank: Top 3%

🔗 View Article (PMID 9049516)

Published in Eur Heart J on January 01, 1997

Authors

A Chauhan1, P A Mullins, G Taylor, M C Petch, P M Schofield

Author Affiliations

1: Regional Cardiac Unit, Papworth Hospital, Cambridge, U.K.

Articles citing this

Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. J Am Coll Cardiol (2010) 2.68

Assessment of coronary flow reserve by sestamibi imaging in patients with typical chest pain and normal coronary arteries. Eur J Nucl Med Mol Imaging (2007) 1.40

Angina pectoris and normal coronary arteries: cardiac syndrome X. Heart (2004) 1.21

In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE). Am Heart J (2011) 1.10

Microvascular coronary dysfunction in women: pathophysiology, diagnosis, and management. Curr Probl Cardiol (2011) 1.08

Role of the vascular endothelium in patients with angina pectoris or acute myocardial infarction with normal coronary arteries. Postgrad Med J (2000) 0.99

Effect of diet-induced weight loss on endothelial dysfunction: early improvement after the first week of dieting. Heart Vessels (2010) 0.84

Effects of nebivolol therapy on endothelial functions in cardiac syndrome X. Heart Vessels (2010) 0.84

Long-term follow-up of patients with cardiac syndrome X treated by spinal cord stimulation. Heart (2007) 0.84

Arterial dysfunction in syndrome X: results of arterial reactivity and pulse wave propagation tests. Heart (2003) 0.81

Cardiac Syndrome X: update 2014. Cardiol Clin (2014) 0.81

Gender and microvascular angina. J Thromb Thrombolysis (2011) 0.81

Insulin resistance as a contributor to myocardial ischaemia independent of obstructive coronary atheroma: a role for insulin sensitisation? Heart (2004) 0.78

Fractional flow reserve: physiological basis, advantages and limitations, and potential gender differences. Curr Cardiol Rev (2015) 0.77

Why study vascular factors in glaucoma? Int Ophthalmol (2000) 0.76

The association of brachial flow-mediated dilation and high-sensitivity C-reactive protein levels with Duke treadmill score in patients with suspected microvascular angina. Exp Clin Cardiol (2012) 0.75

Angina pectoris and normal coronary angiograms. Eur Heart J (1997) 0.75

Improvement in endothelial dysfunction in patients with systemic lupus erythematosus with N-acetylcysteine and atorvastatin. Indian J Pharmacol (2011) 0.75

Articles by these authors

HIV evolution: CTL escape mutation and reversion after transmission. Nat Med (2004) 10.21

Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) Lancet (1996) 6.48

Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat Struct Biol (2000) 4.10

Guideline for the management of breast lumps. Can J Surg (1998) 4.02

Methicillin-resistant Staphylococcus aureus in tertiary care institutions on the Canadian prairies 1990-1992. Infect Control Hosp Epidemiol (1994) 3.27

Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology (1984) 3.27

A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. N Engl J Med (2001) 2.50

Early complications after dual chamber versus single chamber pacemaker implantation. Pacing Clin Electrophysiol (1994) 2.45

The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis. Nat Med (1995) 2.42

Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus. J Virol (1987) 2.41

Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro. J Clin Invest (1987) 2.40

Respiratory syncytial virus. Brief review. Arch Virol (1985) 2.31

Met and hepatocyte growth factor/scatter factor expression in human gliomas. Cancer Res (1997) 2.30

Respiratory syncytial virus infection in mice. Infect Immun (1984) 2.14

Aspirin for unstable angina? Br Med J (Clin Res Ed) (1986) 2.08

A breathless woman with hepatosplenomegaly for 12 years. Lancet (1997) 2.07

What more do we have to do? Br Dent J (1992) 2.04

The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air. N Engl J Med (1990) 2.03

Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells. Immunology (1987) 2.02

Community care. Br Dent J (2001) 2.01

Coronary angiography from the radial artery--experience, complications and limitations. Int J Cardiol (1998) 1.95

Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci U S A (1992) 1.93

Involvement of caveolae in the uptake of respiratory syncytial virus antigen by dendritic cells. J Leukoc Biol (1999) 1.88

Changes in elastic fibres in the small airways and alveoli in COPD. Eur Respir J (2008) 1.87

Cardio-oesophageal reflex in humans as a mechanism for "linked angina'. Eur Heart J (1996) 1.84

Intracoronary injections of salbutamol demonstrate the presence of functional beta 2-adrenoceptors in the human heart. Circ Res (1989) 1.82

A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease. Hum Gene Ther (1996) 1.80

Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts. MBio (2011) 1.76

Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus. J Gen Virol (1992) 1.73

Carcinoembryonic antigen in faeces. Br Med J (1972) 1.71

Effects of active and passive immunization on Mycoplasma pulmonis-induced pneumonia in mice. Immunology (1976) 1.71

Total hip arthroplasty in ankylosing spondylitis: outcome in 340 patients. J Rheumatol (2001) 1.71

Selected aspects of cardiac tumors in infancy and childhood. Pediatr Cardiol (2000) 1.69

Temporary cardiac pacing. Postgrad Med J (1999) 1.69

The three domains of a bacterial sialidase: a beta-propeller, an immunoglobulin module and a galactose-binding jelly-roll. Structure (1995) 1.65

Late complications following permanent pacemaker implantation or elective unit replacement. Heart (1998) 1.63

Crystal structure of Vibrio cholerae neuraminidase reveals dual lectin-like domains in addition to the catalytic domain. Structure (1994) 1.61

Changing fruit and vegetable consumption among children: the 5-a-Day Power Plus program in St. Paul, Minnesota. Am J Public Health (1998) 1.59

Cardioesophageal reflex: a mechanism for "linked angina" in patients with angiographically proven coronary artery disease. J Am Coll Cardiol (1996) 1.57

Ventricular pacemaker upgrade: experience, complications and recommendations. Heart (1998) 1.55

Studies on the aetiology of byssinosis. Br J Ind Med (1971) 1.53

Cytotoxic lymphocytes in the lungs of mice infected with respiratory syncytial virus. J Gen Virol (1985) 1.52

X-ray analyses of aspartic proteinases. II. Three-dimensional structure of the hexagonal crystal form of porcine pepsin at 2.3 A resolution. J Mol Biol (1990) 1.52

Peak expiratory flow meters (PEFMs)--who uses them and how and does education affect the pattern of utilisation? Aust N Z J Med (1994) 1.51

Creating a Canadian stroke system. CMAJ (2001) 1.50

Safety of coronary arteriography. Br Heart J (1973) 1.50

Cross validation of the factor structure of the 20-item Toronto Alexithymia Scale: an Italian multicenter study. J Psychosom Res (1996) 1.49

Strain differences in susceptibility to murine respiratory mycoplasmosis in C57BL/6 and C3H/HeN mice. Infect Immun (1985) 1.49

Coronary angiography in the presence of peripheral vascular disease: femoral or brachial/radial approach? Catheter Cardiovasc Interv (2000) 1.48

The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis. J Virol (1994) 1.46

The accreditation of vocational training programmes--results of a pilot survey. J R Coll Gen Pract (1974) 1.46

Arrhythmias after coronary bypass surgery. Br Heart J (1984) 1.46

Screening for fragile X syndrome: information needs for health planners. J Med Screen (1997) 1.46

Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP). J Antimicrob Chemother (2012) 1.45

Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium. Infect Immun (1995) 1.44

Who needs dual chamber pacing? BMJ (1993) 1.43

A comparative study of anticoagulant control in patients on long-term warfarin using home and hospital monitoring of the international normalised ratio. Arch Dis Child (2007) 1.42

Urban woodlands: their role in reducing the effects of particulate pollution. Environ Pollut (1998) 1.42

Mechanisms of action of Pseudomonas aeruginosa pyocyanin on human ciliary beat in vitro. Infect Immun (1993) 1.42

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

Diagnosis of early cardiac transplant rejection by fall in evoked T wave amplitude measured using an externalized QT driven rate responsive pacemaker. Pacing Clin Electrophysiol (1991) 1.41

Mortality in the CHAOS trial. Lancet (1999) 1.41

Arginine derivatives and uraemia. Lancet (1992) 1.40

Point prevalence survey for healthcare-associated infections within Canadian adult acute-care hospitals. J Hosp Infect (2007) 1.39

Driving and the implantable cardioverter defibrillator. Lancet (1996) 1.39

Baseline fruit and vegetable intake among adults in seven 5 a day study centers located in diverse geographic areas. J Am Diet Assoc (1999) 1.38

Validation study of a Doppler-tipped angiographic catheter for measurement of a coronary flow reserve. Am J Cardiol (1993) 1.38

Use of a generic polymerase chain reaction assay detecting human T-lymphotropic virus (HTLV) types I, II and divergent simian strains in the evaluation of individuals with indeterminate HTLV serology. J Med Virol (1997) 1.36

Aging-associated endothelial dysfunction in humans is reversed by L-arginine. J Am Coll Cardiol (1996) 1.35

Modelling supply and demand of bioenergy from short rotation coppice and Miscanthus in the UK. Bioresour Technol (2010) 1.35

Changes in nasal airways resistance on antigenic challenge in allergic rhinitis. Clin Allergy (1971) 1.34

Assessment of the genetic causes of recessive childhood non-syndromic deafness in the UK - implications for genetic testing. Clin Genet (2005) 1.33

The role of cutaneous diphtheria in the acquisition of immunity. J Hyg (Lond) (1968) 1.33

British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008. HIV Med (2008) 1.33

Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32

Endemic goitre in the Gilgit Agency, West Pakistan with an appendix on dermatoglyphics and taste-testing. Philos Trans R Soc Lond B Biol Sci (1972) 1.32

Syncope. BMJ (1994) 1.31

The natural history of developmental dysplasia of the hip after early supervised treatment in the Pavlik harness. A prospective, longitudinal follow-up. J Bone Joint Surg Br (2002) 1.31

Juvenile myelomonocytic leukemia and Noonan syndrome. J Pediatr Hematol Oncol (2000) 1.30

5-a-day Power Plus: process evaluation of a multicomponent elementary school program to increase fruit and vegetable consumption. Health Educ Behav (2000) 1.30

Risk factor analysis for the major hazards following heart transplantation--rejection, infection, and coronary occlusive disease. Transplantation (1991) 1.27

A comparison of three vaccines against respiratory syncytial virus in calves. J Hyg (Lond) (1984) 1.27

Coronary thrombolytic treatment at home. BMJ (1991) 1.27

Effect of Pseudomonas aeruginosa rhamnolipids on mucociliary transport and ciliary beating. J Appl Physiol (1985) (1992) 1.27

Experience with papillary and solid epithelial neoplasms of the pancreas in children. J Pediatr Surg (1998) 1.27

Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. CMAJ (1999) 1.26

Effect of immunosuppression on arthritis in mice induced by Mycoplasma pulmonis. Ann Rheum Dis (1974) 1.26

Tubulointerstitial nephritis and uveitis in children and adolescents. Four new cases and a review of the literature. Pediatr Nephrol (1999) 1.24

The importance of seeking ALMS1 mutations in infants with dilated cardiomyopathy. J Med Genet (2005) 1.23